Swiss National Bank’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Swiss National Bank’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,500	Closed	-$174K	–	2658
2016 Q1	$174K	Buy	31,500 +5,800	+23%	+$40.5K	﹤0.01%	2572
2015 Q4	$267K	Hold	25,700	–	–	﹤0.01%	2525
2015 Q3	$475K	Buy	25,700 +3,700	+17%	+$71.4K	﹤0.01%	2205
2015 Q2	$428K	Hold	22,000	–	–	﹤0.01%	2310
2015 Q1	$387K	Hold	22,000	–	–	﹤0.01%	2307
2014 Q4	$352K	Hold	22,000	–	–	﹤0.01%	2349
2014 Q3	$277K	Hold	22,000	–	–	﹤0.01%	2359
2014 Q2	$344K	Buy	22,000 +6,500	+42%	+$95.6K	﹤0.01%	2340
2014 Q1	$204K	Buy	15,500 +4,500	+41%	+$70.4K	﹤0.01%	2421
2013 Q4	$177K	Sell	11,000 -8,300	-43%	-$132K	﹤0.01%	2413
2013 Q3	$321K	Sell	19,300 -1,000	-5%	-$14.8K	﹤0.01%	2186
2013 Q2	$204K	Buy	+20,300	New	+$213K	﹤0.01%	2358

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Swiss National Bank's OSIR Position: Q2 2016 in Review

Swiss National Bank sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 31,500 shares — an estimated $174K sold.

Swiss National Bank first reported a position in OSIR in Q2 2013 and held it in 12 quarters. The position peaked at $475K in Q3 2015. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

Swiss National Bank reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Swiss National Bank sold 31,500 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $174K.
Swiss National Bank first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
Swiss National Bank's Osiris Therapeutics, Inc. Common Stock position peaked at $475K in Q3 2015.
68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.